Patients Coming Off Weight-Loss Injections Put On Pounds Four Times Faster Than People Using Diet and Exercise

Fresh analysis indicates that people who come off popular slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who halt traditional diet and exercise plans.

Findings released in a prominent health publication shows that while overweight individuals often shed about a fifth of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing these drugs need to be informed of the danger of quick weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to pre-treatment weight within about 18 months.

Comparing Therapies

The research, which examined 37 of studies involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.

Scientists note that individuals who shed pounds through lifestyle changes alone usually experience a slower weight regain—approximately 100 grams monthly—after stopping.

The Reason for the Fast Regain

Experts suggest the mechanism of the jabs is key to understanding the amplified rebound.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating a significant risk."

A Chronic Issue?

Medical guidelines suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, given the likelihood of relapse, the treatment should be considered long-term.

This opinion is supported by pharmaceutical companies, who say that the results "underscore the chronic character of obesity," akin to managing conditions like hypertension.

User Experiences

Individuals who have stopped the medication explain a sudden return of appetite.

"I experienced a trigger activating and I was suddenly ravenous," described one woman.

This difficulty is compounded if users have not developed permanent dietary or behavioural changes during treatment.

Widespread Adoption

Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with desire remaining high.

• Use is greater among females compared to males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion access the medications through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while the jabs are effective agents for shedding pounds, they are not a magic fix and maintained weight loss relies on integrated lifestyle changes.